Sunday, June 21, 2020

Glenmark Shares Surge Over 35% On Regulatory Approval For COVID-19 Drug

Favipiravir being manufactured by Glenmark will be marketed by the name of Fabiflu and will be available in strength of 200 milligrams.

from NDTV Profit - Latest https://ift.tt/3fNZK2e
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)